Versantis Presents New VS-01 Data at The International Liver CongressTM 2022
VS-01 Reduced Plasma Metabolites Associated with Organ Failures Related to ACLF Metabolomic analysis of organ failure markers abstract selected for inclusion in the ‘Best of International Liver Congress™ 2022’ ZURICH–(BUSINESS WIRE)–Versantis, a clinical-stage biotechnology company developing novel therapies for orphan and pediatric liver diseases, today announced data showing both single and repeated intraperitoneal administrations of … [Read more…]
